Stem Cells

ATLANTA — The 11th Circuit ruled that it lacks jurisdiction over patients’ appeal to intervene in an action between a corporation running a stem cell “bank” and the U.S. Food and Drug Administration, which sued the bank to prevent it from distributing stem cell products until it obtains approval.

%d bloggers like this: